We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Nano Mobile Healthcare Inc (PK) | USOTC:VNTH | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.00005 | -16.67% | 0.00025 | 0.0002 | 0.0003 | 0.00025 | 0.00025 | 0.00025 | 1,000 | 18:21:58 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 14, 2021
NANO MOBILE HEALTHCARE, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware
(State or other jurisdiction of incorporation) |
000-55155
(Commission File Number) |
98-0659770
(I.R.S. Employer Identification No.) |
One
Boston Place Suite 2600
Boston, MA 02108
(Address of Principal Executive Offices and Zip Code)
Registrant’s telephone number, including area code: (877) 626-6681
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
Common Stock, par value of $0.00001 | VNTH | OTCMKTS |
Item 1.01. Entry into a Material Definitive Agreement
On October 14, 2021, pursuant to an effective Settlement Agreement, for undisclosed amount, the Company bought back the Convertible Notes that previous managements sold to VVIS VIRES GROUP, INC. (“VVG”), a corporation formed and existing pursuant to the laws of the State of New York and having a principal place of business located at 111 Great Neck Road, Suite 216, Great Neck, New York 11021.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.
On October 14, 2021 Frank I Igwealor resigned as a member of the Board of Directors (the "Board") of Nano Mobile Healthcare (the "Company"), effective as of the date of such resignation. Mr. Igwealor also resigned as Chairman of the Board and Chief Executive Officer of the Company effective as of such date. Mr. Igwealor's resignation was not the result of any dispute or disagreement with the Company or the Company's Board of Directors on any matter relating to the operations, policies or practices of the Company.
David Noah Kittle has been appointed the President and CEO for the Company effective October 14, 2021.
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits. | ||
Exhibit No. | Description | |
2.1 | 10.15.2021 Press Release | |
10.1 | 10.14.2021 Settlement Agreement |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NANO MOBILE HEALTHCARE, INC.
Date: October 15, 2021 | By: /s/ David N Kittle | |
Name: | David N Kittle | |
Title: | President and CEO |
1 Year Nano Mobile Healthcare (PK) Chart |
1 Month Nano Mobile Healthcare (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions